PubRank

Hiroyuki Azuma

Author PubWeight™ 22.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 2006 2.15
2 Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003 1.32
3 Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. Circulation 2004 1.32
4 High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention. Circulation 2004 1.27
5 Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004 1.24
6 Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem 2005 1.20
7 Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology 2009 0.98
8 Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency. Circ Res 2007 0.97
9 Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases. Clin Chem 2002 0.96
10 Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice. Mol Endocrinol 2010 0.94
11 Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 2002 0.91
12 Infective endocarditis caused by lactobacillus. Intern Med 2008 0.89
13 View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area. Int Arch Med 2010 0.87
14 Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice. J Clin Invest 2007 0.85
15 Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function. Atherosclerosis 2010 0.84
16 Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction. Intern Med 2008 0.80
17 Heparin cofactor II as a novel vascular protective factor against atherosclerosis. J Atheroscler Thromb 2009 0.79
18 Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia--a case report. Angiology 2003 0.79
19 Vascular smooth muscle cell proliferation is dependent upon upregulation of mitochondrial transcription factor A (mtTFA) expression in injured rat carotid artery. Atherosclerosis 2005 0.78
20 Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets. J Atheroscler Thromb 2010 0.77
21 Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease. Acta Neuropathol 2002 0.77
22 Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors. J Atheroscler Thromb 2009 0.77
23 [Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo]. Clin Calcium 2006 0.76
24 Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression. Atherosclerosis 2005 0.75
25 Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome. Circ J 2006 0.75